Psychoimmunology and Aging: A Tribute to George Freeman Solomon

Journal of the American Medical Directors Association

Volumn 16, Issue 11, 2015, Pages 901-904

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; INFLUENZA VACCINE; SACCHARIN;

AGING; COGNITIVE DEFECT; DEPRESSION; EDITORIAL; HUMAN; ILLNESS BEHAVIOR; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGY; MENTAL STRESS; NONHUMAN; PREMATURE AGING; PSYCHOIMMUNOLOGY; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; WOUND HEALING IMPAIRMENT; CAREGIVER; HISTORY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOPHYSIOLOGY;

AGING; CAREGIVERS; HISTORY, 21ST CENTURY; HUMANS; PSYCHONEUROIMMUNOLOGY; STRESS, PSYCHOLOGICAL;

EID: 84947709834     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.08.024     Document Type: Editorial

References (87)

1. Matalnikov S., Chorine V. Classical conditioning modulates immunity. Ann Inst Pasteur 1926, 11:1-8.
2. Ader R., Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975, 37:333-340.
3. Moos R.H., Solomon G.F. Personality correlates of the rapidity of progression of rheumatoid arthritis. Ann Rheum Dis 1964, 23:145-151.
4. Vaillant G.E. Triumphs of Experience: The Men of the Harvard Grant Study 2012, Harvard University Press, Cambridge, MA.
5. Wang H., Schumacher A.E., Levitz C.E., et al. Left behind: Widening disparities for males and females in US county life expectancy, 1985-2010. Popul Health Metr 2013, 11:8.
6. Nolte E., Shkolnikov V., McKee M. Changing mortality patterns in East and West Germany and Poland: I: Long term trends (1960-1997). J Epidemiol Community Health 2000, 54:890-898.
7. Chau P.H., Yen E., Morley J.E., Woo J. The effects of environmental stressors on the mortality of the oldest old male population in Hong Kong, 1977-2006. Aging Male 2008, 11:179-188.
8. Flaherty J.H., Dong B., Wu H., et al. Observational study of 1-year mortality rates before and after a major earthquake among Chinese nonagenarians. J Gerontol A Biol Sci Med Sci 2011, 66:355-361.
9. Solomon G.F., Segerstrom S.C., Grohr P., et al. Shaking up immunity: Psychological and immunologic changes after a natural disaster. Psychosom Med 1997, 59:114-127.
10. Kay N., Allen J., Morley J.E. Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci 1984, 35:53-59.
11. Kay N., Morley J.E., van Ree J.M. Enhancement of human lymphocyte natural killing function by non-opioid fragments of beta-endorphin. Life Sci 1987, 40:1083-1087.
12. Kay N.E., Morley J.E., Allen J.I. Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes. Immunology 1990, 70:485-491.
13. Fiatarone M.A., Morley J.E., Bloom E.T., et al. Endogenous opioids and the exercise-induced augmentation of natural killer cell activity. J Lab Clin Med 1988, 112:544-552.
14. Fiatarone M.A., Morley J.E., Bloom E.T., et al. The effect of exercise on natural killer cell activity in young and old subjects. J Gerontol 1989, 44:M37-M45.
15. Naliboff B.D., Benton D., Solomon G.F., et al. Immunological changes in young and old adults during brief laboratory stress. Psychosom Med 1991, 53:121-132.
16. Naliboff B.D., Solomon G.F., Gilmore S.L., et al. The effects of the opiate antagonist naloxone on measures of cellular immunity during rest and brief psychological stress. J Psychosom Res 1995, 39:345-359.
17. Morley J.E., von Haehling S., Anker S.D., Vellas B. From sarcopenia to frailty: A road less traveled. J Cachexia Sarcopenia Muscle 2014, 5:5-8.
18. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013, 14:392-397.
19. Malmstrom T.K., Miller D.K., Morley J.E. A comparison of four frailty models. J Am Geriatr Soc 2014, 62:721-726.
20. Morley J.E., Malmstrom T.K., Rodriguez-Mañas L., Sinclair A.J. Frailty, sarcopenia, and diabetes. J Am Med Dir Assoc 2014, 15:853-859.
21. Morley J.E. Frailty screening comes of age. J Nutr Health Aging 2014, 18:453-454.
22. Woo J., Leung J., Morley J.E. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012, 60:1478-1486.
23. Morley J.E. Frailty: Diagnosis and management. J Nutr Health Aging 2011, 15:667-670.
24. van Kan G.A., Rolland Y., Bergman H., et al. The IANA task force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008, 12:29-37.
25. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
26. Morley J.E. Frailty: A time for action. Eur Geriatr Med 2013, 4:215-216.
27. Michaud M., Balardy L., Moulis G., et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 2013, 14:877-882.
28. Yeh S.S., Blackwood K., Schuster M.W. The cytokine basis of cachexia and its treatment: Are they ready for prime time?. J Am Med Dir Assoc 2008, 9:219-236.
29. Rohleder N., Marin T.J., Ma R., Miller G.E. Biologic cost of caring for a cancer patient: Dysregulation of pro- and anti-inflammatory signaling pathways. J Clin Oncol 2009, 27:2909-2915.
30. Haren M.T., Malmstrom T.K., Miller D.K., et al. Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: A cross-sectional analysis of a cohort of late middle-aged African Americans. J Gerontol A Biol Sci Med Sci 2010, 65:274-281.
31. Li Y., Zou Y., Wang S., et al. A pilot study of the FRAIL scale on predicting outcomes in Chinese elderly people with type 2 diabetes. J Am Med Dir Assoc 2015, 16:714.e7-714.e12.
32. Garcia-Esquinas E., Graciani A., Guallar-Castillón P., et al. Diabetes and risk of frailty and its potential mechanisms: A prospective cohort study of older adults. J Am Med Dir Assoc 2015, 16:412-419.
33. Lee J.S., Auyeung T.W., Leung J., et al. Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass. J Nutr Health Aging 2011, 15:857-862.
34. Van Hataren J.K., Hendriks S.H., Groenier K.H., et al. Frailty and the relationship between blood pressure and mortality in elderly patients with type 2 diabetes (Zwolle Outpatient Diabetes project Integrating Available Care-34). J Hypertens 2015, 33:1162-1166.
35. Sinclair A., Morley J.E., Rodriquez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012, 13:497-502.
36. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., et al. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A 1996, 93:3043-3047.
37. Konig H.H., Leicht H., Brettschneider C., et al. The costs of dementia from the societal perspective: Is care provided in the community really cheaper than nursing home care?. J Am Med Dir Assoc 2014, 15:117-126.
38. Fredman L., Cauley J.A., Hochberg M., et al. Mortality associated with caregiving, general stress, and caregiving-related stress in elderly women: Results of caregiver-study of osteoporotic fractures. J Am Geriatr Soc 2010, 58:937-943.
39. O'Reilly D., Connolly S., Rosato M., Patterson C. Is caring associated with an increased risk of mortality? A longitudinal study. Soc Sci Med 2008, 57:1282-1290.
40. Schulz R., Beach S.R. Caregiving as a risk factor for mortality: The Caregiver Health Effects study. JAMA 1999, 282:2215-2219.
41. Buyck J.F., Ankri J., Dugravot A., et al. Informal caregiving and the risk of coronary heart disease: The Whitehall II study. J Gerontol A Biol Sci Med Sci 2013, 68:1316-1323.
42. Hasegawa N., Hashimoto M., Koyama A., et al. Patient-related factors associated with depressive state in caregivers of patients with dementia at home. J Am Med Dir Assoc 2014, 15:371.e15-371.e18.
43. Afram B., Stephan A., Verbeek H., et al. Reasons for institutionalization of people with dementia: Informal caregiver reports from 8 European countries. J Am Med Dir Assoc 2014, 15:108-116.
44. de Rooij A.H., Luijkx K.G., Declercq A.G., et al. Professional caregivers' mental health problems and burnout in small scale and traditional long term care settings for elderly people with dementia in the Netherlands and Belgium. J Am Med Dir Assoc 2012, 13:486.e7-486.e11.
45. Bern-Klug M. The emotional context facing nursing home residents' families: A call for role reinforcement strategies from nursing homes and the community. J Am Med Dir Assoc 2008, 9:36-44.
46. Marziali E., Shulman K., Damianakis T. Persistent family concerns in long term care settings: Meaning and management. J Am Med Dir Assoc 2006, 7:154-162.
47. MacNeil Vroomen J., Bosmans J.E., van de Ven P.M., et al. Community-dwelling patients with dementia and their informal caregivers with and without case management: 2-year outcomes of a pragmatic trial. J Am Med Dir Assoc 2015, 16:800.e1-800.e8.
48. Lee T., Chang H. Long term care education program for caregivers to improve home health care service in Korean older adults. J Am Med Dir Assoc 2013, 14:443-444.
49. Beinart N., Weinman J., Wade D., Brady R. Caregiver burden and psychoeducational interventions in Alzheimer's disease: A review. Dement Geriatr Cogn Dis Extra 2012, 2:638-648.
50. Gouin J.P., Hantsoo L., Kiecolt-Glaser J.K. Immune dysregulation and chronic stress among older adults: A review. Neuroimmunomodulation 2008, 15:251-259.
51. Glaser R., Sheridan J., Malarkey W.B., et al. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med 2000, 62:804-807.
52. Vedhara K., Bennett P.D., Clark S., et al. Enhancement of antibody responses to influenza vaccination in the elderly following a cognitive-behavioural stress management intervention. Psychother Psychosom 2003, 72:245-252.
53. Gouin J.P., Glaser R., Malarkey W.B., et al. Chronic stress, daily stressors, and circulating inflammatory markers. Health Psychol 2012, 31:264-268.
54. Li J., Cowden L.G., King J.D., et al. Effects of chronic stress and interleukin-10 gene polymorphisms on antibody response to tetanus vaccine in family caregivers of patients with Alzheimer's disease. Psychosom Med 2007, 69:551-559.
55. Kéri S., Szabó C., Kelemen O. Expression of Toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behav Immun 2014, 40:235-243.
56. Black D.S., Cole S.W., Irwin M.R., et al. Yogic meditation reverses NF-kB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology 2013, 38:348-355.
57. Bierhaus A., Wolf J., Andreassy M., et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003, 100:1920-1925.
58. Lengacher C.A., Kip K.E., Barta M., et al. A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers. J Holist Nurs 2012, 30:170-185.
59. von Känel R., Dimsdale J.E., Mills P.J., et al. Effect of Alzheimer caregiving stress on frailty markers interleukin-6, C-reactive protein, and D-dimer. J Gerontol A Biol Sci Med Sci 2006, 61:963-969.
60. Gouin J.P., Kiecolt-Glaser J.K. The impact of psychological stress on wound healing: Methods and mechanisms. Crit Care Nurs Clin North Am 2012, 24:201-213.
61. Shattuck E.C., Muehlenbein M.P. Human sickness behavior: Ultimate and proximate explanations. Am J Phys Anthropol 2015, 157:1-18.
62. Poon D.C., Ho Y.S., Chiu K., Chang R.C. Cytokines: How important are they in mediating sickness?. Neurosci Biobehav Rev 2013, 37:1-10.
63. Tizard I. Sickness behavior, its mechanisms and significance. Anim Health Res Rev 2008, 9:87-99.
64. Banks W.A., Moinuddin A., Morley J.E. Regional transport of TNF-alpha across the blood-brain barrier in young ICR and young and aged SAMP8 mice. Neurobiol Aging 2001, 22:671-676.
65. Robertson D.A., Savva G.M., Kenny R.A. Frailty and cognitive impairment-a review of the evidence and causal mechanisms. Ageing Res Rev 2013, 12:840-851.
66. Beyer I., Njemini R., Bautmans I., et al. Inflammation-related muscle weakness and fatigue in geriatric patients. Exp Gerontol 2012, 47:52-59.
67. Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1alpha impairs memory processing in mice: Dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 2001, 299:536-541.
68. Canevelli M., Cesari M., van Kan G.A. Frailty and cognitive decline: How do they relate?. Curr Opin Clin Nutr Metab Care 2015, 18:43-50.
69. Halil M., Cemal Kizilarslanoglu M., Emin Kuyumcu M., et al. Cognitive aspects of frailty: Mechanisms behind the link between frailty and cognitive impairment. J Nutr Health Aging 2015, 19:276-283.
70. Buchman A.S., Bennett D.A. Cognitive frailty. J Nutr Health Aging 2013, 17:738-739.
71. Kelaiditi E., Cesari M., Canevelli M., et al. Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging 2013, 17:726-734.
72. Woods A.J., Cohen R.A., Pahor M. Cognitive frailty: Frontiers and challenges. J Nutr Health Aging 2013, 17:741-743.
73. Malmstrom T.K., Morley J.E. Frailty and cognition: Linking two common syndromes in older persons. J Nutr Health Aging 2013, 17:723-725.
74. Gibertini M. Cytokines and cognitive behavior. Neuroimmunomodulation 1998, 5:160-665.
75. Morley J.E. White matter lesions (leukoaraiosis): A major cause of falls. J Am Med Dir Assoc 2015, 16:441-443.
76. Peng J., Lu F., Wang Z., et al. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc 2014, 15:904-910.
77. Morley J.E. Is it possible to prevent injurious falls?. Eur Geriatr Med 2014, 5:75-77.
78. Ogama N., Sakurai T., Shimizu A., Toba K. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer's disease. J Am Med Dir Assoc 2014, 15:36-41.
79. Rouhl R.P., Damoiseaux J.G., Lodder J., et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging 2012, 33:1800-1806.
80. Heneka M.T., Carson M.J., El Khoury J., et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol 2015, 14:388-405.
81. Nuzzo P., Picone P., Caruana L., et al. Inflammatory mediators as biomarkers in brain disorders. Inflammation 2014, 37:639-648.
82. Stewart A.M., Roy S., Wong K., et al. Cytokine and endocrine parameters in mouse chronic social defeat: Implications for translational "cross-domain" modeling of stress-related brain disorders. Behav Brain Res 2015, 276:84-91.
83. Haapakoski R., Mathieu J., Ebmeier K.P., et al. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 2015, 49:206-215.
84. Morley J.E., Caplan G., Cesari M., et al. International survey of nursing home research priorities. J Am Med Dir Assoc 2014, 15:309-312.
85. Rolland Y., Tolson D., Morley J.E., Vellas B. The International Association of Gerontology and Geriatrics (IAGG) nursing home initiative. J Am Med Dir Assoc 2014, 15:307-308.
86. Tolson D., Rolland Y., Andrieu S., et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011, 12:184-189.
87. Pugh E.M. The Biological Origin of Human Values 1978, 154. Basic Books, New York, NY.